Skip to main content
logo
Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
2.020
-0.060 (-2.88%)
At close: Sep 8, 2026, 4:00 PM EDT
2.300
+0.220 (10.58%)
Pre-market: Sep 9, 2026, 5:31 AM EDT

Jin Medical International Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
1.171.193.682.882.712.63
Depreciation & Amortization
0.310.350.350.230.360.35
Loss (Gain) From Sale of Assets
0.040.040-0.01-0.01
Provision & Write-off of Bad Debts
0.10.11-0.050.120.03-0.11
Other Operating Activities
-0.430.12-0.260.09-0.09-0
Change in Accounts Receivable
0.32.27-3.91-0.380.333.08
Change in Inventory
-1.670.170.081.56-0.50.48
Change in Accounts Payable
-0.60.29-0.5-0.65-0.81-0.37
Change in Unearned Revenue
0.14-0.17-0.060.02-0.760.65
Change in Income Taxes
-0.3-0.790.820.030.16-0.1
Change in Other Net Operating Assets
0.35-0.67-1.35-0.780.15-0.78
Operating Cash Flow
-0.592.9-1.213.111.585.84
Operating Cash Flow Growth
---96.53%-72.95%133.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
-6.37-6.63-0.14-0.11-0.04-0.04
Sale of Property, Plant & Equipment
0000.01--
Cash Acquisitions
--0.5----
Sale (Purchase) of Intangibles
---0.98---
Investment in Securities
-0.02-3.66-8.39-7.63-0.45-0.81
Other Investing Activities
----0.36-0.22
Investing Cash Flow
-6.38-10.79-9.51-7.73-0.12-1.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Short-Term Debt Issued
-19.0216.95.670.120.77
Total Debt Issued
26.6219.0216.95.670.120.77
Short-Term Debt Repaid
--11.57-5.56-5.89--3.64
Total Debt Repaid
-21.97-11.57-5.56-5.89--3.64
Net Debt Issued (Repaid)
4.657.4611.34-0.210.12-2.87
Issuance of Common Stock
--0.318.34--
Other Financing Activities
-0.1-0.1--1.21--
Financing Cash Flow
4.547.3511.656.910.12-2.87

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Foreign Exchange Rate Adjustments
0.38-0.140.27-0.15-0.460.1
Net Cash Flow
-2.05-0.671.212.141.122.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-6.96-3.73-1.352.991.545.8
Free Cash Flow Growth
---94.25%-73.44%145.69%
Free Cash Flow Margin
-35.28%-18.01%-5.75%15.10%8.03%27.93%
Free Cash Flow Per Share
-0.89-0.48-0.170.410.230.86
Levered Free Cash Flow
-7.49-5.110.69-1.571.344.07
Unlevered Free Cash Flow
-7.49-5.110.69-1.571.344.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
0.530.410.240.01-0.07
Cash Income Tax Paid
0.570.560.210.140.010.3
Change in Working Capital
-1.781.1-4.92-0.2-1.432.96
SEC Filings: 10-K · 10-Q